Tag: Market
RSV Prophylactic Beyfortus: Potential Competitors and Market Trends
Alnylam Pharmaceuticals, led by CEO Yvonne Greenstreet, is making strides in expanding the use of its RNA-based gene-silencing heart drug, vutrisiran. The drug has...
BREAKING NEWS
NIH Funding Approved for Women’s Health Initiative
Elizabeth Cooney, who's a cardiovascular disease reporter at STAT, is covering heart, stroke, and metabolic conditions. On Monday, the Women’s Health Initiative said the...
